Fennec Pharmaceuticals Inc. (FENC) vs Shoulder Innovations, Inc. (SI)
A side-by-side comparison of Fennec Pharmaceuticals Inc. and Shoulder Innovations, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FENC
Fennec Pharmaceuticals Inc.
$10.23HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
SI
Shoulder Innovations, Inc.
$19.69HealthcareDelayed quote: Oct 6, 2026, 10:28 AM EDT
Total return — FENC vs SI
growth of $100 · dividends reinvested · last 1yFENC +26.3% (+26.3%/yr)SI +30.2% (+30.2%/yr)SI compounded faster over this window
FENC SI
FENC vs SI: by the numbers
- •SI is the larger company ($408M vs $355M market cap).
- •Both run net losses; FENC's is the smaller (-5.49% vs -58.33% net margin).
Metrics side by side
Valuation
| Metric | FENC | SI |
|---|---|---|
| Forward P/E | 36.11 | N/A |
| P/S ratio | 6.00 | 6.80 |
| P/B ratio | 8.37 | 3.28 |
Profitability
| Metric | FENC | SI |
|---|---|---|
| Gross margin | 93.73% | 77.34% |
| Operating margin | -14.22% | -58.53% |
| Net margin | -5.49% | -58.33% |
| ROE | -7.66% | -28.18% |
| ROIC | -1.84% | -25.26% |
Growth (annualized)
| Metric | FENC | SI |
|---|---|---|
| Revenue CAGR (5Y) | 222.46% | N/A |
| Total return CAGR (5Y) | 2.45% | N/A |
Go deeper
Dig into the metrics
Fennec Pharmaceuticals ROEShoulder Innovations ROEFennec Pharmaceuticals operating marginShoulder Innovations operating marginFennec Pharmaceuticals revenue growthShoulder Innovations revenue growthFennec Pharmaceuticals free cash flowShoulder Innovations free cash flow
Fennec Pharmaceuticals & Shoulder Innovations appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.